Skip to main content
NCBI home page
Journal of Urban Health : Bulletin of the New York Academy of Medicine logoLink to Journal of Urban Health : Bulletin of the New York Academy of Medicine
. 1998 Sep 1;75(3):558–583. doi: 10.1007/BF02427704

Addiction treatment: Promoting a medical approach to substance use

Gary L Stein 1, Alan R Fleischman 1
PMCID: PMC5587447  PMID: 9762650

Executive summary

Building on decades of Academy activities related to substance use, this report emphasizes three guiding principles:

  1. Drug treatment should be accessible to all drug users seeking care, including those who are incarcerated. Because turning users away when programs are operating at or above capacity represents lost opportunities for care, programs should be prepared to commence treatment at the time users request it.

  2. Addiction is a complex, chronic, relapsing illness for which various inpatient, residential, and outpatient treatments are used, depending on the substances involved, the intensity and duration of the addiction, the characteristics and tolerances of the patient, and the circumstances involved. Optimal addiction treatment requires generalists in medical care who are knowledgeable and capable in the areas of diagnosis and management; specialist consultation and care; specific programs dedicated to the acute and chronic care of drug users; and the multidisciplinary participation of appropriately qualified counselors, social workers, and other professionals.

  3. Steps need to be taken to reduce the health-related harms associated with injection drug use, including the transmission of human immunodeficiency virus (HIV), hepatitis B and C, and other blood-borne pathogens. Harm reduction incorporates many modalities, such as HIV prevention education, including condom use and safer sex counseling and education; referrals for drug treatment and other health care and social services; interim methadone maintenance; and syringe and needle availability and exchange programs. Each of these interventions represents important medical and public health strategies that may decrease some of the secondary medical consequences of injection drug use.

Full Text

The Full Text of this article is available as a PDF (1.5 MB).

References

  • 1.Schmoke KL. Medicalizing the war on drugs. Acad Med. 1995;70:356–356. doi: 10.1097/00001888-199505000-00009. [DOI] [PubMed] [Google Scholar]
  • 2.Committee on Public Health Relations, The New York Academy of Medicine . Thirty Years in Community Service: 1911–1941. New York: The New York Academy of Medicine; 1941. pp. 69–71. [PMC free article] [PubMed] [Google Scholar]
  • 3.Committee on Public Health, The New York Academy of Medicine . Pioneering in Public Health for 50 Years. New York: The New York Academy of Medicine; 1961. pp. 92–92. [Google Scholar]
  • 4.Proceedings: Symposium on Drug Testing in the Workplace.Bull NY Acad Med. 1989; 65(2).
  • 5.Proceedings: Pregnancy and Substance Abuse: Perspectives and Directions.Bull NY Acad Med. 1991;67(3). [PMC free article] [PubMed]
  • 6.Committee on Public Health, The New York Academy of Medicine Statement on AIDS initiatives in drug treatment services in New York City. Bull NY Acad Med. 1991;67:403–403. [PMC free article] [PubMed] [Google Scholar]
  • 7.The New York Academy of Medicine . A Statement on Allowing Non-prescription Possession and Sale of Hypodermic Needles and Syringes. New York: The New York Academy of Medicine; 1991. [Google Scholar]
  • 8.The New York Academy of Medicine Harm reduction polices and practice: international developments and domestic initiatives. Bull NY Acad Med. 1995;72:321–412. [PMC free article] [PubMed] [Google Scholar]
  • 9.Institute of Medicine . Federal Regulation of Methadone Treatment. Washington, DC: National Academy Press; 1995. pp. 5–6. [Google Scholar]
  • 10.Kent C. Experts fear “get tough” view of drug treatment may backfire. Am Med News. 1996;16:29. [Google Scholar]
  • 11.National Research Council . AIDS: Sexual Behavior and Intravenous Drug Use. Washington, DC: National Academy Press; 1989. pp. 211–211. [PubMed] [Google Scholar]
  • 12.National Commission on AIDS . America Living with AIDS: Report of the National Commission on Acquired Immune Deficiency Syndrome. Washington, DC: US Government Printing Office; 1991. pp. 9–9. [Google Scholar]
  • 13.Citizens Commission on AIDS for New York City and Northern New Jersey.AIDS and Drug Use: Breaking the Link. 1988:1–2. [PubMed]
  • 14.New Hope for Addicts? [editorial] New York Times. 1996;13:A34. [Google Scholar]
  • 15.American Psychiatric Association Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. Am J Psychiatry. 1995;152:39–43. doi: 10.1176/ajp.152.11.1. [DOI] [PubMed] [Google Scholar]
  • 16.Foderaro LW. An alternative to methadone is approved: New York clinics see new hope for addicts.New York Times. September 6, 1996:B1.
  • 17.Ball JC, Ross A. The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services, and Outcome. New York: Springer US; 1991. pp. 239–240. [Google Scholar]
  • 18.Novick DM, Joseph H, Salsitz EA, et al. Outcomes of treatment of socially rehabilitated methadone maintenance patients in physicians' offices (medical maintenance) J Gen Int Med. 1994;9:130–130. doi: 10.1007/BF02600025. [DOI] [PubMed] [Google Scholar]
  • 19.Wren CS. One of medicine's best-kept secrets: methadone works.New York Times. June 3, 1997:C-3.
  • 20.37Federal Register 26790.
  • 21.Yancovitz SR, Des Jarlais JC, Peyser NP, et al. A randomized trial of an interim methadone maintenance clinic. Am J Public Health. 1995;81:1185–1185. doi: 10.2105/AJPH.81.9.1185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.New York State Assembly.An Act to amend the public health law, in relation to methadone treatment. Bill A-9278. Introduced by Assemblymember Tocci of Westchester County. March 5, 1996.
  • 23.New York State Assembly.Memorandum in Support of Legislation. Bill A-8937. Introduced by Assemblymember Tocci of Westchester County and six cosponsors. February 26, 1996.
  • 24.Nadelmann E, McNeely J. Doing methadone right. Public Interest. 1996;123:83–83. [Google Scholar]
  • 25.DeLeon G, Rosenthal M. Therapeutic communities. In: DuPont RL, Goldstein A, O'Donnell J, editors. Handbook on Drug Abuse. Washington, DC: US Government Printing Office; 1979. pp. 40–40. [Google Scholar]
  • 26.Hubbard RL, Marsden ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzberg HM. Drug Abuse Treatment: a National Study of Effectiveness. Chapel Hill, NC: University of North Carolina Press; 1989. pp. 55–64. [Google Scholar]
  • 27.Reuters. Use of drugs while pregnant is ruled abuse.New York Times. July 17, 1996: A10.
  • 28.Lewin T. Abuse laws cover fetus, a high court rules.New York Times. October 30, 1997: A22.
  • 29.Lewin T. Court rules out woman's trial in fetus death.New York Times. October 31, 1997:A16.
  • 30.Murphy PT. Protect the innocent.New York Times. July 30, 1996:A17.
  • 31.Terry D. In Wisconsin, a rarity of a fetal-harm case: attempted-murder charges for alcoholic.New York Times. August 17, 1996:A6.
  • 32.Cooper JR. Including narcotic addiction treatment in an office-based practice. JAMA. 1995;273:1619–1619. doi: 10.1001/jama.1995.03520440073040. [DOI] [PubMed] [Google Scholar]
  • 33.Sirica C, editor. Training About Alcohol and Substance Abuse for All Primary Care Physicians: a Conference Sponsored by the Josiah Macy, Jr., Foundation. New York: Josiah Macy, Jr., Foundation; 1995. [Google Scholar]
  • 34.Gilbert S. Doctors found to fail in diagnosing addictions.New York Times. March 14, 1996.
  • 35.Van Brussel G. Methadone treatment by general pratitioners in Amsterdam. Bull NY Acad Med. 1995;72:348–348. [PMC free article] [PubMed] [Google Scholar]
  • 36.Newman RG. Drug policy reform: societal and clinical perspectives. Bull NY Acad Med. 1995;72:321–321. [PMC free article] [PubMed] [Google Scholar]
  • 37.Frank B, Galea J. Current drug use trends in New York City. In: National Institute on Drug Abuse.Epidemiological Trends in Drug Abuse, Vol. 2. December 1995:167–168.
  • 38.New York State Office of Alcoholism and Substance Abuse Services . 1992–1993 OASAS data. Cited by: Institute of Medicine.Federal Regulation of Methadone Treatment. Washington, DC: National Academy Press; 1995. pp. 170–173. [Google Scholar]
  • 39.Dao J. Pataki renews call to limit home relief: says US welfare law will strain state budget. September. 1996;29:39. [Google Scholar]
  • 40.Eisenhandler J, Drucker E. Opiate dependency among the subscribers of a New York area private insurance plan. JAMA. 1993;269(22):2891–2891. doi: 10.1001/jama.1993.03500220076030. [DOI] [PubMed] [Google Scholar]
  • 41.Richardson H, Califano J, Tapper D, Demers J. Substance abuse and public health in urban America: analysis of costs in New York City. Curr Issues Public Health. 1996;2:98. [Google Scholar]
  • 42.New York State AIDS Advisory Council, Subcommittee on Harm Reduction . Report on Needle Exchange Programs and Deregulation of Needles and Syringes. New York: New York State AIDS Advisory Council; 1996. pp. 8–8. [Google Scholar]
  • 43.Gerstein DR, Johnson RA, Harwood HJ, Fountain D, Suter N, Malloy K. Evaluating Recovery Services: the California Drug and Alcohol Treatment Assessment (CALDATA)—General Report. Sacramento, Calif: California Department of Alcohol and Drug Programs; 1994. [Google Scholar]
  • 44.Paone D, Des Jarlais DC, Gangloff R, Milliken J, Friedman SR. Syringe exchange: HIV prevention, key findings, and future directions. Int J Addict. 1995;30:1651–1651. doi: 10.3109/10826089509104419. [DOI] [PubMed] [Google Scholar]
  • 45.New York State Public Health Law, §3381.
  • 46.10Official Compilation of Codes, Rules, and Regulations of the State of New York, Part 80.135.
  • 47.Public Law 102-394, 106 Stat 1827, §514 (October 6, 1993) (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act).
  • 48.US General Accounting Office . Needle Exchange Programs: Research Suggests Promise as an AIDS Prevention Strategy. Washington, DC: US Government Printing Office; 1993. [Google Scholar]
  • 49.Shalala DE. Needle Exchange Programs in America: Review of Published Studies and Ongoing Research—Report to the Committee on Appropriations for the Departments of Labor, Health and Human Services, Education, and Related Agencies. Washington, DC: US Department of Health and Human Services; 1997. pp. 11–11. [Google Scholar]
  • 50.Lurie P. When science and politics collide: the federal response to needle-exchange programs. Bull NY Acad Med. 1995;72:380–380. [PMC free article] [PubMed] [Google Scholar]
  • 51.Seelye KQ. AMA calls for needle exchanges.New York Times. June 27, 1997.
  • 52.Clean needles slow AIDS [editorial].New York Times. December 6, 1994.
  • 53.Coming clean about needle exchange.Lancet 1995;346:1377. [PubMed]
  • 54.National Research Council/Institute of Medicine . Preventing HIV Transmission: the Role of Sterile Needles and Bleach. Washington, DC: National Academy Press; 1995. pp. 4–4. [PubMed] [Google Scholar]
  • 55.Lurie P, Reingold AL, Bowser B, et al. The Public Health Impact of Needle Exchange Programs in the United States and Abroad. San Francisco, Calif: University of California; 1993. [Google Scholar]
  • 56.Des Jarlais DC, Paone D, Marmor M, Titus S, Sotheran JL, Friedman SR. The New York City syringe exchange program: evaluation of a public health intervention. Paper presented at: American Public Health Association Conference; November 1994; Washington, DC; Tables 1 and 2.
  • 57.Des Jarlais DC, Paone D. Presentation to the New York State AIDS Advisory Council Subcommittee on Harm Reduction, March 22, 1996. Cited by: New York State AIDS Advisory Council, Subcommittee on Harm Reduction.Report on Needle Exchange Programs and Deregulation of Needles and Syringes. New York: New York State AIDS Advisory Council; April 1996:6.
  • 58.Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348:987–987. doi: 10.1016/S0140-6736(96)02536-6. [DOI] [PubMed] [Google Scholar]
  • 59.Lurie P, Drucker E. An opportunity lost: estimating the number of preventable HIV infections and cost of US failure to implement syringe exchange programs. Paper resented at: 11th International Conference on AIDS; July 1996; Vancouver, Canada (Doc. ID: Tu.C.324).
  • 60.Lurie P, Drucker E. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. Lancet. 1997;349:604–604. doi: 10.1016/S0140-6736(96)05439-6. [DOI] [PubMed] [Google Scholar]
  • 61.Groseclose SL, Weinstein B, Jones TS, Valleroy LA, Fehrs LJ, Kassler WJ. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers—Connecticut, 1992–1993. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10:82–89. doi: 10.1097/00042560-199509000-00012. [DOI] [PubMed] [Google Scholar]
  • 62.Diaz T, Chu SY, Weinstein B, et al. Factors associated with syringe sharing among HIV-infected drug injectors: influence of knowledge of HIV status and change in prescription laws. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(suppl. 1):576–581. doi: 10.1097/00042560-199802001-00014. [DOI] [PubMed] [Google Scholar]
  • 63.Gostin LO, Lazzarini Z, Jones TS, Flaherty K. Prevention of HIV/AIDS and other blood-borne diseases among injection drug users: a national survey on the regulation of syringes and needles. JAMA. 1997;277:56–57. [PubMed] [Google Scholar]
  • 64.Hantman JA. Research on needle exchange: redefining the agenda. Bull NY Acad Med. 1995;72:82–89. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Urban Health : Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES